Apriem Advisors’s CONMED CNMD Stock Holding History

Apriem Advisors’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-419	Closed	-$31K	–	186
2018 Q2	$31K	Buy	+419	New	+$28.5K	0.01%	290
2017 Q2	–	Sell	-411	Closed	-$18K	–	210
2017 Q1	$18K	Buy	411 +1	+0.2%	+$43	﹤0.01%	356
2016 Q4	$18K	Buy	410 +2	+0.5%	+$85	0.01%	367
2016 Q3	$16K	Buy	408 +2	+0.5%	+$85	﹤0.01%	352
2016 Q2	$19K	Buy	406 +2	+0.5%	+$85	0.01%	344
2016 Q1	$17K	Buy	404 +2	+0.5%	+$78	0.01%	323
2015 Q4	$18K	Buy	402 +2	+0.5%	+$87	0.01%	313
2015 Q3	$19K	Buy	400 +1	+0.3%	+$55	0.01%	298
2015 Q2	$23K	Buy	399 +2	+0.5%	+$108	0.01%	299
2015 Q1	$20K	Buy	397 +1	+0.3%	+$49	0.01%	317
2014 Q4	$18K	Buy	396 +2	+0.5%	+$84	0.01%	311
2014 Q3	$15K	Buy	394 +2	+0.5%	+$79	0.01%	329
2014 Q2	$17K	Buy	392 +2	+0.5%	+$91	0.01%	288
2014 Q1	$17K	Buy	390 +2	+0.5%	+$89	0.01%	314
2013 Q4	$16K	Buy	388 +2	+0.5%	+$76	0.01%	307
2013 Q3	$13K	Buy	386 +1	+0.3%	+$33	0.01%	321
2013 Q2	$12K	Buy	+385	New	+$12.5K	0.01%	311

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Apriem Advisors's CNMD Position: Q3 2018 in Review

Apriem Advisors sold out of CONMED (CNMD) in Q3 2018, closing a stake of 419 shares — an estimated $31K sold.

Apriem Advisors first reported a position in CNMD in Q2 2013 and held it in 17 quarters. The position peaked at $31K in Q2 2018. 207 funds tracked by Wall St. Rank hold CNMD as of Q3 2018.

Apriem Advisors reported no remaining CONMED position as of Q3 2018 after selling out during the quarter.
Apriem Advisors sold 419 CONMED shares in Q3 2018, an estimated $31K.
Apriem Advisors first reported a position in CONMED in Q2 2013 and held it in 17 quarters.
Apriem Advisors's CONMED position peaked at $31K in Q2 2018.
207 funds tracked by Wall St. Rank held CONMED as of Q3 2018.

Based on Apriem Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.